Biotechnology News

November 6, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in light of repeated clinical trial failures of investigational treatments,...

November 6, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--SCYNEXIS today announced that results of a Phase 2a study of lead candidate SCY-635 for the treatment of the hepatitis C virus (HCV) will be the subject of an oral presentation at AASLD in Boston.

November 6, 2012

PHILADELPHIA--(BUSINESS WIRE)--The Shire ADHD Scholarship is for individuals in the US diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) who are pursuing higher education.

November 6, 2012

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: The following summons to the Annual General Meeting will be available at Diamyd Medical's website www.diamyd.com from Thursday...

November 6, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that four abstracts containing new data on treatment with Feraheme® (ferumoxytol) Injection for intravenous (IV) use in patients with iron deficiency...

November 6, 2012

NORWALK, Conn.--(BUSINESS WIRE)--A three-and-a-half-year review report of the biotechnology industry reveals a consistent slump in the M&A market.

November 6, 2012

DAVIS, Calif.--(BUSINESS WIRE)--Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, has been chosen by AlwaysOn for a second consecutive year...

November 6, 2012

PROVIDENCE, R.I.--(BUSINESS WIRE)--Beech Tree Labs, Inc. announced today that it has completed a successful Phase 2a clinical evaluation of its novel therapeutic agent, UISH001, for treating urinary incontinence (UI).

November 6, 2012

EXTON, Penn.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that while Biogen Idec’s Avonex and Teva’s Copaxone continue to capture almost one-...

November 6, 2012

RESEARCH TRIANGLE PARK, NC--(BUSINESS WIRE)--New Product Planning groups contribute market approval strategies early for valuable compounds, find Cutting Edge Information.

November 6, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Cutting Edge Information’s research finds tracking key metrics, such as including physician reach, enhances medical publication teams’ value.

November 6, 2012

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (TASE: KMDA), an Israeli biopharmaceutical company, specializing in development, manufacturing and marketing of specialty plasma bio-therapeutics by intravenous or inhaled route for life saving...

November 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today highlighted its recent clinical and business progress and reported its financial results for the third quarter of 2012. “We have made strong progress across...

November 6, 2012

RIO DE JANEIRO--(BUSINESS WIRE)--CryopraxisTM/CellPraxis® aims to start patient recruitment for its Phase III Refractory Angina Cell Therapy Brazilian arm clinical trial by the end of 2012 or early 2013. The phase IIA/B clinical trial study was...

November 6, 2012

ST. LOUIS--(BUSINESS WIRE)--Partek Flow, a web-based application for next generation sequencing applications including RNA-Seq, small RNA-Seq, Exome, and Targeted sequencing has been added to Illumina’s BaseSpace Apps.

November 6, 2012

ATLANTA--(BUSINESS WIRE)--Clearside Biomedical announces the successful dosing of patients in a clinical study using a proprietary ocular microinjection platform to deliver drugs to treat retinal disease

November 6, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today reported financial results for the third quarter ended September 30, 2012 and provided clinical program updates regarding its lead oncology drug ...

November 6, 2012

BEND, Ore.--(BUSINESS WIRE)--Bend, Oregon-based CRO/CMO, Agere, Enhances Spray Drying cGMP Capabilities to Serve Clients with One-stop-shopping

November 6, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix introduces high-density genotyping solution for genome-wide analysis of microRNA target sites, especially relevant for cancer genomics research. Preliminary study results presented at ASHG.

November 6, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today reported third quarter 2012 financial results and...

November 6, 2012

AUSTIN, Texas--(BUSINESS WIRE)--Expanded leadership will advance Austin-based start-up company, Ortho Kinematics, Inc.

November 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the Lazard Capital Markets 9th Annual Healthcare Conference on Tuesday, November 13, 2012 at...

November 6, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview on November 13, 2012 at the Lazard Capital Markets 9th Annual Healthcare Conference in New York City. The GTx presentation...

November 6, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, M.D., President and Chief Executive Officer will present at the Lazard Capital Markets 9th Annual Healthcare Conference on Tuesday, November...

November 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Paragonix 510(k) Pre-Marketing Notification, Sherpa Pak Cardiac Transport System

November 6, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that it has filed a patent infringement lawsuit against Cellectis.

November 6, 2012

BERLIN--(BUSINESS WIRE)--Today Janssen Healthcare Innovation, a team within Janssen Research & Development, LLC (Janssen), announced the winners of the Janssen Connected Health Challenge Europe 2012 in partnership with Health 2.0. This crowd-...

November 6, 2012

DUBLIN--(BUSINESS WIRE)--ICON Launches New Functional Service Provision (FSP) Strategy
FSP and resourcing services consolidated into a single division, DOCS

November 6, 2012

MILAN, Italy--(BUSINESS WIRE)--Sorin Group announced today the U.S. commercial launch of the Mitroflow Valsalva Conduit, the only Valsalva conduit graft approved by the U.S. FDA for use in combination with an aortic tissue valve.

November 6, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--New real-world data reinforces the positive safety and efficacy profile of Pradaxa® (dabigatran etexilate) in clinical practice for the prevention of venous thromboembolism (VTE) in patients undergoing total...

November 6, 2012

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: As part of Sogeti's focus on mobile applications, the company has entered into a partnership with Precise Biometrics, the market-leading provider of solutions for secure mobile access. Demand...

November 6, 2012

AUCKLAND, New Zealand--(BUSINESS WIRE)--Biomatters today adds Molecular Profiler application to Illumina’s BaseSpace Apps. The Molecular Profiler is a beautifully rendered, remotely managed and securely delivered cloud-based genome browser

November 6, 2012

LOS ANGELES--(BUSINESS WIRE)--Researchers present findings today at AHA Scientific Sessions: HDL3 subclasses measured with the VAP Lipid Panel are inversely associated with heart disease risk in African Americans.

November 5, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tcelna™, a novel T-cell therapy for multiple sclerosis (MS), announced today that it has signed a purchase agreement on November 5, 2012 for the...

November 5, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB: ILIU) announces it will host a conference call and Webcast on Wednesday, November 14, 2012 at 4:30 p.m. ET to discuss the Company’s third quarter results.

November 5, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics (CLDX) announces that results from CDX-301 Phase 1 study will be presented in a poster session at ASH 2012 Annual Meeting on 12/10/2012 at 6:00 pm ET.

November 5, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) announced today that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will present at three investor conferences later this month. Lazard...

November 5, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today that three abstracts on its humanized anti-CD37 mono-specific protein therapeutic, TRU-016, and bispecific protein therapeutics have been accepted for...

November 5, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced preliminary financial results for the three months ended September 30, 2012 and provided a business update. In a separate announcement made today...

November 5, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced plans to restate financial statements for 2011 and the first two quarters of 2012. Ligand’s Audit Committee, in consultation with management has...

November 5, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ:CLVS) today reported financial results for the third quarter 2012, and provided an update on the progress of its clinical development programs and expected milestones for the rest of...

November 5, 2012

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced...

November 5, 2012

FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. Reports Third Quarter 2012 Financial Results

November 5, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the third quarter of 2012. Total revenue for the quarter was $79.6 million, including approximately $17.6 million in revenue from...

November 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter 2012, and company highlights. “The highlights of this...

November 5, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops anticancer therapeutics using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the following...

November 5, 2012

NEWARK, Del.--(BUSINESS WIRE)--SDIX (Nasdaq: SDIX) - a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology and diagnostic applications - expects to release its third quarter 2012 results...

November 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited (TSE:4502) today announced that more than 60 abstracts from studies involving five molecules in the Company’s...

November 5, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that more than a dozen abstracts, in addition to several collaborator abstracts, for both ADCETRIS (brentuximab vedotin) and investigational antibody-drug...